EUVIMEDEUVIMED entdecken
Crossref

Eplontersen for Transthyretin Amyloid Cardiomyopathy

Marianna Fontana iD, Ahmad Masri, Scott D Solomon iD, Francesco Cappelli, Margot K Davis, Pablo García-Pavía, Julian D Gillmore iD, Mazen Hanna, Laura Obici, Brett W Sperry, Nobuhiro Tahara iD, Márcia Waddington-Cruz und 14 weitere

New England Journal of Medicine · 28.08.2026

DOI: 10.1056/nejmoa2608510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, online erschienen am 28.08.2026. Verfasst von Marianna Fontana und 25 weiteren Autor:innen. Beteiligte Einrichtung: National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Ionis Pharmaceuticals, AstraZeneca.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London.
  • Division of Cardiovascular Medicine, Oregon Health and Sciences University, Portland.
  • Cardiovascular Division, Brigham and Women's Hospital, Boston.
  • Tuscan Regional Amyloidosis Center, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy.
  • Division of Cardiology, University of British Columbia, Vancouver, Canada.
  • Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro, Madrid.

ORCID-Profile: Marianna Fontana, Scott D Solomon, Julian D Gillmore, Nobuhiro Tahara, Olga Azevedo, Mathew S Maurer

Förderung

  • Ionis Pharmaceuticals
  • AstraZeneca

Zitieren

APA

Fontana, M., Masri, A., Solomon, S. D., Cappelli, F., Davis, M. K., García-Pavía, P., Gillmore, J. D., Hanna, M., Obici, L., Sperry, B. W., Tahara, N., Waddington-Cruz, M., Azevedo, O., Damy, T., de Barros Correia, E., Khouri, M. G., Nikolova, A. P., Störk, S., Conrad, T., …, & CARDIO-TTRansform Investigators (2026). Eplontersen for Transthyretin Amyloid Cardiomyopathy. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2608510

Vancouver

Fontana M, Masri A, Solomon SD, Cappelli F, Davis MK, García-Pavía P, et al. Eplontersen for Transthyretin Amyloid Cardiomyopathy. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2608510

BibTeX
@article{Fontana2026,
  author = {Fontana, Marianna and Masri, Ahmad and Solomon, Scott D and Cappelli, Francesco and Davis, Margot K and García-Pavía, Pablo and Gillmore, Julian D and Hanna, Mazen and Obici, Laura and Sperry, Brett W and Tahara, Nobuhiro and Waddington-Cruz, Márcia and Azevedo, Olga and Damy, Thibaud and de Barros Correia, Edileide and Khouri, Michel G and Nikolova, Andriana P and Störk, Stefan and Conrad, Tom and Yang, Qingqing and Claggett, Brian L and Chen, Jersey and Brice, Gary T and Tsimikas, Sotirios and Maurer, Mathew S and CARDIO-TTRansform Investigators, CARDIO-TTRansform Investigators},
  title = {Eplontersen for Transthyretin Amyloid Cardiomyopathy},
  journal = {New England Journal of Medicine},
  year = {2026},
  doi = {10.1056/nejmoa2608510}
}
Kostenlos starten →